COMMENTARY
·
SUBSCRIBERS

5 key issues confronting investors now

Tariff fears, reshoring and AI bubble among worries for those on both sides of the Pacific

    • Should Singapore’s US$1.4 billion in IPO proceeds in the year to Sep 25 – a 40-fold increase over 2024’s full-year total – scare you? No. That jump is a return to health.
    • Should Singapore’s US$1.4 billion in IPO proceeds in the year to Sep 25 – a 40-fold increase over 2024’s full-year total – scare you? No. That jump is a return to health. PHOTO: BT FILE
    Published Mon, Oct 6, 2025 · 07:00 AM

    [SINGAPORE] What has you worried? The Straits Times Index (STI) and US stocks are notching all-time highs – alongside many other markets. Yet, abundant fears remain.

    Here are five big issues confronting investors on both sides of the Pacific. And a peek at how you can fathom what others miss.

    1. Will US President Donald Trump’s threatened pharmaceutical tariffs whack drugmakers?

    The 100 per cent levy on branded or patented drugs sounds scary. But step back.

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    Copyright SPH Media. All rights reserved.